Taro_Fujimori

Taro Fujimori

Taro Fujimori is a Director of Regulatory Affairs CMC at Ultragenyx. Taro has worked on early-phase, late-phase, and post-approval biologic products including gene therapies, mAbs, fusion proteins, non-recombinant proteins, imaging antibodies, and antibody drug conjugates. Taro has a Bachelors from the University of Pennsylvania, a PhD from Brandeis University, and an MBA from Columbia Business School. Taro has earned US, EU, and Global Regulatory Affairs Certifications.


Appearances